Carica Papaya - A multicentric double blind homoeopathic pathogenetic trial

Abstract

Objective: To elicit the pathogenetic response of the drug Carica papaya in homoeopathic potencies on healthyhuman volunteers. Methodology : Drug Carica papaya was proved by the Central Council for Research in Homoeopathy through double-blind placebo-controlled method. The study was conducted at 2 centres. The drug was proved in three potencies (6C, 30C and 200C) on 26 apparently healthy volunteers who were selected after conducting pre-trial medical examination by the medical specialists and routine laboratory investigations. In the first phase volunteers were given 56 doses (04 doses per day for 14 days) of placebo. In the next three phases 56 doses (04 doses per day for 14 days) of each potency or placebo were consumed. The symptoms generated during the trial period were noted by the volunteers, cross examined and elaborated by the Proving Masters. The data obtained from both the centres was compiled at proving-cum-data processing cell at CCRH headquarters after decoding. Observations : Drug was able to produce symptoms in each potency more or less related to every part of the body. Conclusion : Pathogenetic responses (new and reproved) elicited during the proving trial expands the scope of use of the drug Carica papaya and will benefit the research scholars and clinicians. These symptoms will carry more value when verified clinically.